[Form 4] Perfect Moment Ltd. Insider Trading Activity

Rhea-AI Filing Summary

Perfect Moment Ltd. director Adam Z. Epstein reported a grant of 65,758 employee stock options on 10/01/2025. Each option has an exercise price of $0.46 and expires on 10/01/2035. The award vests in four tranches: 16,440 options vest and become exercisable on 12/31/2025, 16,440 on 03/31/2026, 16,439 on 06/30/2026, and 16,439 on 09/30/2026. Following the grant, Mr. Epstein beneficially owns 65,758 underlying common shares via direct ownership of the options. The Form 4 was signed on 10/09/2025.

Positive

• Options align executive incentives with long‑term share performance via staged vesting through 09/30/2026
• Long 10‑year term (until 10/01/2035) gives time for value creation before expiration

Negative

• Potential future dilution of 65,758 shares if options are exercised
• Low exercise price ($0.46) could lead to dilution if market price rises above that level

Insights

Compensation & Governance Analyst

Director received time‑based options that align pay with long‑term share value.

The grant of 65,758 options at an exercise price of $0.46 uses a multi‑quarter vesting schedule ending 09/30/2026, tying potential reward to future share performance over the next year. The 10‑year term to 10/01/2035 provides a long runway for value realization if the share price rises above the exercise price.

This award is standard for board-level incentive practices; monitor actual exercise activity and total dilution if similar grants are made company‑wide over the next 12–24 months.

Equity Dilution Specialist

Grant increases potential share count but immediate dilution is contingent on exercise.

Those 65,758 options represent potential future issuance of common stock upon exercise; they do not change outstanding share count until exercised. The low exercise price of $0.46 may incentivize exercise only if market price exceeds that level.

Investors should track total outstanding options and any future grants to estimate dilution impact over the next 1–3 years, particularly if multiple insiders receive comparable awards.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Epstein Adam Zachary

(Last) (First) (Middle)

244 FIFTH AVENUE

SUITE 1219

(Street)

NEW YORK NY 10001

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Perfect Moment Ltd. [ PMNT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Options (right to buy)(1)	$0.46	10/01/2025		A		65,758		12/31/2025(2)	10/01/2035	Common Stock	65,758	(3)	65,758	D

Explanation of Responses:

1. Employee stock options (right to buy) ("Options") granted pursuant to Issuer's 2021 Equity Incentive Plan, as amended.

2. Options vest and are exercisable as follows: 16,440 Options on December 31, 2025 and March 31, 2026, and 16,439 Options on June 30, 2026 and September 30, 2026.

3. Not applicable.

Remarks:

	/s/ Adam Z. Epstein	10/09/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Perfect Moment (PMNT) director Adam Z. Epstein receive?

He was granted 65,758 employee stock options with an exercise price of $0.46, expiring on 10/01/2035.

When do the granted options vest and become exercisable?

The options vest in four tranches: 16,440 on 12/31/2025, 16,440 on 03/31/2026, 16,439 on 06/30/2026, and 16,439 on 09/30/2026.

Does this Form 4 show shares were sold or bought?

No. The filing reports an option grant (A); it does not show exercise or sale of underlying shares.

How does this affect Perfect Moment's outstanding shares?

There is no immediate change to outstanding shares; dilution would occur only if and when the 65,758 options are exercised.

Who filed the Form 4 and when was it signed?

The reporting person is Adam Z. Epstein (a director), and the form was signed on 10/09/2025.